BIOAVAILABILITY OF HIGH-DOSE METOCLOPRAMIDE

被引：0
|
作者：
TAYLOR, WB [1 ]
BATEMAN, DN [1 ]
机构：
[1] UNIV NEWCASTLE UPON TYNE,WOLFSON UNIT CLIN PHARMACOL,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P296 / P296
页数：1
相关论文
共 50 条
  • [21] TARDIVE-DYSKINESIA ASSOCIATED WITH HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE
    BREITBART, W
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08): : 518 - 518
  • [22] PREVENTING CYTOSTATIC-INDUCED VOMITING WITH HIGH-DOSE METOCLOPRAMIDE
    ELL, C
    KONIG, HJ
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 108 (24) : 962 - 962
  • [23] ANTIEMETIC PROPHYLAXIS WITH HIGH-DOSE METOCLOPRAMIDE OR LORAZEPAM IN VOMITING INDUCED BY CHEMOTHERAPY
    BOWCOCK, SJ
    STOCKDALE, AD
    BOLTON, JAR
    KANG, AA
    RETSAS, S
    BRITISH MEDICAL JOURNAL, 1984, 288 (6434): : 1879 - 1879
  • [24] HIGH-DOSE METOCLOPRAMIDE IN CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    BUI, NB
    MARIT, G
    HOERNI, B
    CANCER TREATMENT REPORTS, 1982, 66 (12): : 2107 - 2108
  • [25] HIGH-DOSE METOCLOPRAMIDE AND DEXAMETHASONE AS AN ANTIEMETIC IN CHEMOTHERAPY OF BREAST-CANCER
    GEZ, E
    GOODMAN, S
    ISACSON, R
    GERRA, C
    SULKES, A
    ONCOLOGY, 1986, 43 (03) : 173 - 175
  • [26] HIGH-DOSE METOCLOPRAMIDE AND CHLORPROMAZINE IN THE TREATMENT OF CISPLATIN-INDUCED EMESIS
    AASEBO, U
    SLORDAL, L
    PRYTZ, PS
    AARBAKKE, J
    PHARMACOLOGY & TOXICOLOGY, 1987, 60 (05): : 337 - 339
  • [27] ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE IN CYTOSTATIC CHEMOTHERAPY
    SCHUTTE, J
    NIEDERLE, N
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1983, 108 (18) : 720 - 720
  • [28] COMPARISON OF THE ANTIEMETIC EFFECT OF HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE AND HIGH-DOSE INTRAVENOUS HALOPERIDOL IN A RANDOMIZED DOUBLE-BLIND CROSSOVER STUDY
    GRUNBERG, SM
    GALA, KV
    LAMPENFELD, M
    JAMIN, D
    JOHNSON, K
    CARIFFE, P
    STRYCH, D
    KRAILO, M
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) : 782 - 787
  • [29] BIOAVAILABILITY OF LOW-DOSE VS HIGH-DOSE 6-MERCAPTOPURINE
    ARNDT, CAS
    BALIS, FM
    MCCULLY, CL
    JEFFRIES, SL
    DOHERTY, K
    MURPHY, R
    POPLACK, DG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 588 - 591
  • [30] HIGH-DOSE METOCLOPRAMIDE + LORAZEPAM VERSUS LOW-DOSE METOCLOPRAMIDE + LORAZEPAM + DEHYDROBENZPERIDOL IN THE TREATMENT OF CISPLATIN-INDUCED NAUSEA AND VOMITING
    HERRSTEDT, J
    HANNIBAL, J
    HALLAS, J
    ANDERSEN, E
    LAURSEN, LC
    HANSEN, M
    ANNALS OF ONCOLOGY, 1991, 2 (03) : 223 - 227
12345